Unity Biotechnology Inc (UBX)

Stock price, financials, and technical signals for Unity Biotechnology Inc (UBX).

$2.24

-0.010

(-0.44%)

As of 01/29/2025 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

UBX Performance Snapshot


1-Week Chg

7.18%

1-Month Chg

124.22%

3-Month Chg

60.00%

6-Month Chg

54.48%

1-Year Chg

28.00%

Year-To-Date Chg

96.49%

Beta 1-Year

-0.01

Beta 5-Year

1.01

Volatility (10-Day)

14.54%

UBX Technicals



Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-01-29

$2.24

-$0.01 (-0.44%)

$2.26

$2.42

$2.15

$2.27

116.52K ($261.00K)

2025-01-28

$2.25

$0.10 (4.65%)

$2.38

$2.45

$2.20

$2.30

241.28K ($542.88K)

2025-01-27

$2.15

-$0.23 (-9.66%)

$2.01

$2.28

$2

$2.14

488.63K ($1.05M)

2025-01-24

$2.38

-$0.19 (-7.39%)

$2.70

$2.85

$2.31

$2.51

672.64K ($1.60M)

2025-01-23

$2.57

$0.48 (22.97%)

$2.19

$3.10

$2.17

$2.61

2.08M ($5.35M)

2025-01-22

$2.09

$0.30 (16.76%)

$1.81

$2.20

$1.80

$2.03

537.78K ($1.12M)

2025-01-21

$1.79

$0.06 (3.47%)

$1.75

$1.84

$1.73

$1.79

210.41K ($376.63K)

2025-01-17

$1.73

$0.04 (2.37%)

$1.71

$1.75

$1.66

$1.71

124.59K ($215.53K)

2025-01-16

$1.69

$0 (0%)

$1.67

$1.70

$1.61

$1.67

138.39K ($233.87K)

2025-01-15

$1.69

-$0.02 (-1.17%)

$1.73

$1.77

$1.56

$1.67

230.75K ($389.97K)

UBX Financials


Balance Sheet

(USD)

2024 Q3

Y/Y CHANGE


  • Cash and equivalents

    $8.90M

    12.98%

  • Total assets

    $47.13M

    -31.96%

  • Total liabilities

    $32.99M

    -0.23%

  • Total investments

    $21.04M

    -46.01%

  • Shareholders' equity

    $14.14M

    -60.93%

  • Book value per share

    $0.84

    -66.17%


Income Statement

(USD)

2024 Q3

Y/Y CHANGE


  • Revenue

    $0

    0%

  • Net income

    -$6.48M

    57.61%

  • Operating expense

    $6.60M

    -55.78%

  • Gross profit

    $0

    0%

  • EBITDA

    -$6.26M

    56.83%

  • Earnings per share

    -$0.38

    63.81%


Cash Flow

(USD)

2024 Q3

Y/Y CHANGE


  • Net change in cash

    $1.31M

    111.69%

  • Cash from operations

    -$5.19M

    27.00%

  • Cash from investing

    $6.51M

    -54.33%

  • Cash from financing

    $0

    100.00%

  • Free cash flow

    -$5.19M

    27.20%

  • Free cash flow per share

    -$0.31

    36.89%


Metrics

(USD)

2024 Q3

Y/Y CHANGE


  • Market capitalization

    $24.77M

    -29.33%

  • Enterprise value

    $38.84M

    -34.18%

  • Shares outstanding

    16.85M

    15.38%

  • Profit margin

    -

    -

  • Gross margin

    -

    -

  • EBITDA margin

    -

    -


Dividends

(USD)

2024 Q3

Y/Y CHANGE


  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    3.44

    -39.96%


Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.